Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 139Esophageal Neoplasms 125Pancreatic Neoplasms 96Esophageal Squamous Cell Carcinoma 84Colorectal Neoplasms 66Adenocarcinoma Of Esophagus 53Stomach Neoplasms 40Carcinoma, Hepatocellular 40Colonic Neoplasms 19Anus Neoplasms 18Neoplasms 14Liver Neoplasms 12Cholangiocarcinoma 10Adenocarcinoma 8Carcinoma, Squamous Cell 7Bile Duct Neoplasms 7Anal Canal Carcinoma 7Head and Neck Neoplasms 6Breast Neoplasms 6Brain Neoplasms 6Prostatic Neoplasms 5Neoplasm Metastasis 5Melanoma 5Lung Neoplasms 5Gastrointestinal Neoplasms 5Gallbladder Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 4Sarcoma 4Vulvar Neoplasms 3

Interventions

Gemcitabine 15130-nm albumin-bound paclitaxel 10Albumin-Bound Paclitaxel 7Oxaliplatin 5Paclitaxel 4Leucovorin 4Fluorouracil 4Carboplatin 4Cisplatin 3Cetuximab 3Bevacizumab 3pembrolizumab 2napabucasin 2Pemetrexed 2PEGPH20 2MK-4721 2Irinotecan 2tremelimumab 1selinexor 1relacorilant 1ponatinib 1neratinib 1irinotecan sucrosofate 1folfirinox 1ensituximab 1durvalumab 1contrast agent BR1 1cobimetinib 1ceritinib 1cc-486 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Pancreatic Ductal × Radiotherapy × Gastrointestinal × Clear all
NCT02243007 2017-05-16

Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer

Massachusetts General Hospital

Phase 2 Terminated
7 enrolled 8 charts
Gastrointestinal

Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡